Z-Trp-Lys(Boc)-NH2

Catalog No. :
ACJLXS374
CAS No. :
323187-30-0
Molecular Formula :
C30H39N5O6
Molecular Weight :
565.67

IUPAC Name:tert-butyl ((S)-6-amino-5-((S)-2-(((benzyloxy)carbonyl)amino)-3-(1H-indol-3-yl)propanamido)-6-oxohexyl)carbamate

Z-Trp-Lys(Boc)-NH2 structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameZ-Trp-Lys(Boc)-NH2
IUPAC Nametert-butyl ((S)-6-amino-5-((S)-2-(((benzyloxy)carbonyl)amino)-3-(1H-indol-3-yl)propanamido)-6-oxohexyl)carbamate
Molecular FormulaC30H39N5O6
Molecular Weight565.67
SMILESO=C(N[C@@H](CCCCNC(OC(C)(C)C)=O)C(N)=O)[C@H](CC1=CNC2=CC=CC=C12)NC(OCC3=CC=CC=C3)=O
InChI KeyFOXYPBFVPQJYCK-DQEYMECFSA-N
Synonymtert-butyl N-[(5S)-6-amino-5-[[(2S)-3-(1H-indol-3-yl)-2-(phenylmethoxycarbonylamino)propanoyl]amino]-6-oxohexyl]carbamate;L-Lysinamide, N-[(phenylmethoxy)carbonyl]-L-tryptophyl-N6-[(1,1-dimethylethoxy)carbonyl]-
CAS No.323187-30-0

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACJLXS374 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACAOVU758 route compound structure diagram
    ACAOVU758112803-72-2 In Stock
  2. Plus
  3. ACQGLN245 route compound structure diagram
    ACQGLN2457432-21-5 In Stock
  4. Then
  5. ACJLXS374 route product structure diagram
    ACJLXS374323187-30-0
Inquiry

2. ACJLXS374 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACAYOL972 route compound structure diagram
    ACAYOL97210060-13-6 In Stock
  4. Then
  5. ACJLXS374 route product structure diagram
    ACJLXS374323187-30-0
Inquiry

Comments (0)